Dezhan Healthcare Company Limited (SZSE:000813) commences share repurchases on September 6, 2022, under the program mandated by the shareholders in the Extraordinary General Meeting held on May 26, 2022. As per the mandate, the company is authorized to repurchase its A shares for a total of CNY 345 million. The shares will be purchased at a price not exceeding CNY 5.4 per share.

The repurchased shares will be cancelled thereby reducing the registered capital. The program will be funded from company's own funds. The program will be valid for 12 months from the date of the shareholder's meeting.